Zobrazeno 51 - 60
of 93
pro vyhledávání: '"Hatem A. Abuelizz"'
Autor:
Ahmed H. Bakheit, Ahmed M. Naglah, Fahd A. Nasr, Hatem A. Abuelizz, Hanem M. Awad, Rashad Al-Salahi, Ali S. Alqahtani, Mohamed Marzouk
Publikováno v:
RSC Advances. 9:19065-19074
A series of 4-(1H-1,2,4-triazol-1-yl)benzoic acid hybrids (1–17) was successfully synthesized and their structures were established by NMR and MS analysis. In vitro cytotoxic evaluation indicated that some of the hybrids exhibited potent inhibitory
Autor:
Mohamed Marzouk, Hatem A. Abuelizz, Anouar ElHassane, Abdulrahman A. Almehizia, Rashad Al-Salahi, Hanan A. A. Taie
Publikováno v:
Saudi Pharmaceutical Journal, Vol 27, Iss 1, Pp 133-137 (2019)
Previously, a series of 2-phenoxy-benzo[g]triazoloquinazolines 1–16 were synthesized and fully characterized. The antioxidant activity of the target molecules 1–16 was evaluated using three different assays namely 1,1-diphenyl-2-picryl hydrazyl (
Autor:
Hatem A. Abuelizz, Ali Osman S. Altoum, Manzar Sohail, Khalid H. Omer, Ali Alhoshani, Anvarhusein A. Isab, Saeed Ahmad, Muhammad Altaf, Adam A.A. Seliman
Publikováno v:
Polyhedron. 158:234-240
Seven trans platinum(II) complexes of selenones having the general formula, trans-[Pt(NH3)2(selenone)2](NO3)2 have been synthesized and characterized using elemental analysis, IR, and NMR (1H & 13C & 77Se) spectroscopy. The crystal structure of one o
Autor:
Mohamed Marzouk, I. T. Ibrahim, Rashad Al-Salahi, Hatem A. Abuelizz, Abdulrahman I. Alharthi, Khalid A. Alburikan, M. A. Motaleb, Moustapha E. Moustapha
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 8, Pp 1120-1126 (2018)
3-Benzyl-2-((3-methoxybenzyl)thio)benzo[g]quinazolin-4(3H)-one was previously synthesized and proved by physicochemical analyses (HRMS, 1H and 13C NMR). The target compound was examined for its radioactivity and the results showed that benzo[g]quinaz
Autor:
Hatem A. Abuelizz, Ali Alhoshani, Amany Z. Mahmoud, Iman S. Issa, Huda S. Al-Salem, Arifuzzaman, A. F. M. Motiur Rahman
Publikováno v:
Applied Sciences
Volume 10
Issue 11
Applied Sciences, Vol 10, Iss 3669, p 3669 (2020)
Volume 10
Issue 11
Applied Sciences, Vol 10, Iss 3669, p 3669 (2020)
Developing anticancer therapeutics with no/few side effects is a challenge for medicinal chemists. The absence of antibacterial activity of an anticancer drug removes its detrimental effect toward intestinal flora and therefore leads to reduced side
Autor:
Ahmed H. Bakheit, Nasser S. Al-Shakliah, Hanem M. Awad, Mohamed Marzouk, Hatem A. Abuelizz, Ahmed M. Naglah, Fahd A. Nasr, Rashad Al-Salahi
Publikováno v:
Bioorganic chemistry. 102
Thirteen 4-hydrazinobenzoic acid derivatives were elaborated and characterized by spectral analyses (NMR and MS). Evaluation of their in vitro cytotoxic activity showed that some of the targets demonstrated potent inhibitory effects against HCT-116 a
Autor:
Mizaton Hazizul Hasan, Hatem A. Abuelizz, Mohamed Marzouk, Siti Rohani Saleh, El Hassane Anouar, Rashad Al-Salahi, Adi Ahudhaif, Khalid A. Alburikan
Publikováno v:
Anti-cancer agents in medicinal chemistry. 20(14)
Background: The use of tyrosinase has confirmed to be the best means of recognizing safe, effective, and potent tyrosinase inhibitors for whitening skin. Twenty-four 2-phenoxy(thiomethyl)pyridotriazolopyrimidines were synthesized and characterized in
Autor:
Rashad Al-Salahi, Nor Izzati Iwana Nor Azman, Rohaya Ahmad, Hatem A. Abuelizz, Mohamed Marzouk, El Hassane Anouar
Publikováno v:
Future Medicinal Chemistry. 10:1889-1905
Aim: Using a simple modification on a previously reported synthetic route, 3-benzyl(phenethyl)-2-thioxobenzo[g]quinazolin-4(3H)-ones (1 and 2) were synthesized with high yields. Further transformation of 1 and 2 produced derivatives 3-26, which were
Publikováno v:
Future Medicinal Chemistry. 10:379-390
Aim: The present study was carried out to assess a new series of triazoloquinazolines 1–40 for their antioxidant activities using 1,1-diphenyl-2-picryl hydrazyl radical scavenging, ferric reduction antioxidant power and reducing power capability as
Autor:
Ahmed Alghamdi, Hatem A. Abuelizz, Mansour Almetwazi, Yousif A. Asiri, Yazed AlRuthia, Mansour Adam Mahmoud, Nasser F BinDhim, Tariq M. Alhawassi, Khalid A. Alburikan, Peter J. Pitts
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 1, Pp 71-74 (2018)
Low-quality medicines deliver sub-optimal clinical outcomes and waste precious health resources. It is important to ensure that public funds are spent on healthcare technologies that meet national regulatory bodies such as the Saudi Food and Drug Aut